Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Manufacturing
VintaBio assets for sale as CGT production sector slows
VintaBio, which made viral vectors for cell and gene therapy production, had its manufacturing facility and intellectual property put up for sale.
Joseph Keenan
Nov 5, 2026 9:55am
Amgen names internal successor as quality chief retires
Nov 3, 2026 3:21pm
Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business
Nov 3, 2026 9:21am
Hansoh written up after FDA inspections
Nov 2, 2026 2:56pm
Fresenius targets €370B originator market with WuXi Bio deal
Nov 2, 2026 9:43am
Pfizer's flooded India injectables plant faces long recovery
Oct 30, 2026 10:20am
